When we innovate for those with the least access, we innovate better, creating health and wealth for all
Discover safe medicines
Develop early clinical validation
Phase one
Distribute equitably
Access for all
Medicine made for the global south reaps huge benefits the world over
Suppressed tumor growth and reduced volume in mouse model
Anti-tumor and anti-angiogenic activity in chicken membrane
Promoted apoptosis in numerous cancer cell lines
More L.I.F.E. solutions in development
- Suppressed tumor growth and reduced volume in mouse model
- Anti-tumor and anti-angiogenic activity in chicken membrane
That’s why I’m fighting for health access for all
- 2%
83% of the global population lives in developing countries. But, they receive only 2% of the R&D spend on health.
- 1%
90% of the global disease burden is located in the global south. Only 1% of health research funding addresses diseases predominantly affecting the global south, like NTDs.
- 2.4T
The fastest growing health markets are emerging in global south. Healthcare spend is expected to reach 2.4 trillion dollars.
We can save tens of millions of lives by treating preventable diseases. And, we can expand the wealth of consumers and investors alike while we do so.
10M
The LivFul Team
Our impact is driven by innovative entrepreneurs and organizations across the world
Yaw Nsarkoh
Chairman of the board
Hogan Bassey
Founder & Co-CEO
Matt Elsberry
Co-Chief Executive Officer
Alexander Zomignani
CEO, Therapeutics
Andy Mahler
Co-Founder and CEO, Global Health
Dr. John Ridden
Chief Scientific Officer
Dr. Luiz Pianowski
Global Director, R&D
Kevin Engel
Chief Finance Officer
John Manwell
Chief Operations Officer
Today’s investors will be at the forefront of global health
Global health
